# The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

> **NCT01699360** · PHASE4 · UNKNOWN · sponsor: **Central South University** · enrollment: 600 (estimated)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Cyclosporine A, Tacrolimus, Sirolimus

## Key facts

- **NCT ID:** NCT01699360
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699360, "The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01699360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*